Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Mendelian Inheritance Error: Familial relationships and sample swaps
Dr. Katie Rudd, PhD, FACMG
Medical Director, Cytogenetics and Genomic Microarray Lab
ARUP Laboratories
In this tips and tricks webinar Dr Katie Rudd talks about ARUP’s experience in understanding the role of the Mendelian Inheritance Error (MIE) tool to investigate unrelated and identical sample swaps, confirm familial relationships, and demonstrate non-parentage.
Utility of a custom targeted genotyping array for carrier screening research
Dr. Linda Hasadsri, PhD
Director, Molecular Technologies Laboratory
Chair of Equity, Inclusion, and Diversity (EID)
Department of Laboratory Medicine and Pathology, Mayo Clinic
Despite professional medical society recommendations to offer carrier screening for over 100 different germline disorders to all individuals of reproductive age, insurance coverage for large panels continues to remain a barrier to widespread adoption. Moreover, not all laboratories have the operational means to implement such testing at the cost, turnaround time, and throughput typically required in the setting of prenatal care.
In this webinar, Linda Hasadsri, director of the molecular technologies laboratory at Mayo Clinic, will present the pros and cons of utilizing a custom targeted genotyping array for carrier screening of over 200 different genetic disorders, our unique approach to supplemental coverage and confirms, and, finally, our discovery yield in the first 8,000 samples received for testing.
SNP Chromosomal Microarray, the allelic difference
Dr. Elizabeth McCready PhD, FACMG
Associate Professor, Department of Pathology and Molecular Medicine
McMaster University
Head of Molecular Cytogenetics
Hamilton Regional Laboratory Medicine Program (HRLMP) Genetics Laboratories
Although not originally well-highlighted as an advantage of chromosome microarray testing, allelic patterns of single nucleotide polymorphic (SNP) loci have also emerged as an important tool to detect relevant chromosome aberrations that may not be apparent by more classical cytogenetic approaches.
In this short webinar, through examination of several exceptional cases, Dr. McCready showcases the utility of the SNP variant allele difference pattern to investigate simple and complex chromosome rearrangements.
The importance of SNP allele patterns to identify regions of homozygosity and possible uniparental disomy will also be explored through examples highlighting the flexibility and versatility of SNP allelic difference patterns as a complimentary, indispensable tool in the molecular cytogenetic testing tool box.
Challenging microarray cases and the approaches for analysis of unusual findings
Stuart Schwartz, PhD, FACMG
Strategic Director, Cytogenetics, Women’s Health and Genetics
Labcorp
Microarray analysis continues to be an important technology in cytogenetics laboratories.
Not all findings are straightforward, and a combination of copy number variants (CNV) and SNP alleles must be utilized to resolve the underlying anomalies and their mechanism of formation.
In this short webinar, learn from Dr. Schwartz as he speaks to several novel and unusual prenatal and oncology cases.
Topics include:
Your partners at Thermo Fisher Scientific would like to invite you to our case review video series. These presentations will focus on some of the most interesting cases giving further evidence that chromosomal microarray remains an important tool in the armamentarium for the investigation of chromosome abnormalities causing a range of congenital and developmental phenotypes.
Determining the genetic cause of disease by application of exon-level array as a complement to exome sequencing
Dr. Benjamin Hilton
Assistant Director of the Cytogenomics Laboratory
Greenwood Genetics Center
Whole-exome sequencing (WES) and whole-genome microarray have allowed for the discovery of a wide variety of diseases that are associated with aberrations in the genome. However, these technologies may not detect some exon-level copy number variation (CNV), leaving cases unsolved. The implementation of an exon-level array has allowed for the evaluation of exon-level CNVs that previously were either difficult to identify or missed entirely by other testing methods.
By bridging the gap of detection between these technologies, Dr. Hilton illustrates how an answer can be attained.
Topics include:
Case #1 Hybrid SNP array analysis in action: a practical approach to complex problems in the era of NGS
Dr. Catherine Rehder, PhD
Associate Professor of Pathology and Director, Division of Molecular Pathology, Genetics and Genomics
Duke University
These cases will demonstrate the power of using both a SNP-based analysis combined with high resolution DNA copy number analysis in the identification of chromosome abnormalities and genetic aberrations in researching pregnancy loss and genetic syndromes.
Topics include:
Case #2 Hybrid SNP array analysis in action: a practical approach to complex problems in the era of NGS
Dr. Kristen Deak, PhD
Associate Director of Cytogenetics and Molecular Laboratories, Division of Molecular Pathology, Genetics and Genomics
Duke University
In this episode, Dr. Deak will illustrate complex chromosomal rearrangements and rare events including insertional duplications.
Topics include:
Case #3 Hybrid SNP array analysis in action: a practical approach to complex problems in the era of NGS
Dr. Kristen Deak, PhD
Associate Director of Cytogenetics and Molecular Laboratories, Division of Molecular Pathology, Genetics and Genomics
Duke University
This final episode with Dr. Deak focuses on challenging chromosome rearrangements such as unbalanced insertions and inversions. Showcasing the value of microarray that ultimately found the answer to an otherwise unsolved question.
Topics include:
Using hybrid-SNP microarrays to delineate UPD in cytogenetic samples
Stuart Schwartz, PhD, FACMG
Strategic Director, Cytogenetics, Women’s Health and Genetics
Labcorp
Discover how hybrid-SNP Arrays made a difference in real world studies of complex genetic cases. Dr. Stuart Schwartz talks about how the use of hybrid-SNP arrays in identifying UPD may increase the success of diagnosis in future.
Topics include:
For Research Use Only. Not for use in diagnostic procedures.